Direct hit — you just found exactly what your practice was looking for.
Everything your longevity practice prescribes — ordered at wholesale, sourced across a multi-pharmacy 503A/503B network, shipped to your patients, financed at the point of decision, and documented with a full clinical suite — all under one login.
Wholesale only — never direct to consumer
Stop Searching and Start Prescribing
For the established physician who just landed here searching for the most advanced longevity platform available — you found it.
Everything your practice prescribes — wholesale, sourced across a U.S. 503A/503B network, shipped to your patients, financed at the point of decision, and documented with a full clinical suite — under one login.
The kind of practice PrescribeUSA was built to power
7 YRSTechnology
400+Offices live
PrescribeUSA is a B2B healthcare commerce and distribution platform — one operating environment where a practice reviews, orders, uses, and distributes GLP-1s, peptides, hormone replacement, IV therapies, and the wider longevity formulary.
01
Built first
Seven years of technology, built quietly before the category had a name.
02
Live for real
Two-plus years in live operation on real practices — not a plan.
03
Proven at scale
400+ doctor offices running on it today, and more joining every day.
Seasoned entrepreneur partners built this on their own capital, not a raise. Every claim here — sourcing, clinical tools, fulfillment, financing — is demonstrated live, on screen, in a professional appointment you can book today.
02 · THE STANDARD
Respect is the difference
This category has a shark problem, and we are willing to name it. The longevity space is crowded with fakes, hype merchants, and vendors who treat a medical practice's time as if it were free. Practices are chased by appointment setters, buried in slideware, and sold features that do not exist by people who will not be around in a year. We operate differently, and the differences are deliberate.
Wholesale only, to approved practices. PrescribeUSA sells wholesale to verified medical practices and providers. We do not sell direct to the consumer. The practice owns its patients; we power the practice. That line does not move.
We respect practice time. A practice owner's hours belong to patients, staff, and growth. Every promise we make is either demonstrated in a live session or it does not get made. No pressure funnels, no mystery pricing, no chasing.
Verification over adjectives. We would rather hand you a live demonstration and a documented sourcing standard than a page of superlatives. In a space full of sharks, the highest form of service and technology is the kind you can check.
Infrastructure over trends. Seven years of technology and two-plus years of live operation happen by building quietly, correctly, and to documented standards: LegitScript verified, HIPAA-oriented architecture, board-certified physician oversight, sourcing exclusively through U.S. 503A/503B pharmacies, and U.S. practices only.
We are particular about the practices we serve, and the practices on the platform prefer it that way. Approval is verification, not a paywall: a practice is onboarded as a verified medical business, and wholesale access is granted to that practice alone. The standards are part of the product.
03 · THE PROBLEM WE WERE BUILT TO END
The frustration every longevity practice already lives with
You know this story already, because you are living it. One portal for supplements. Another for GLP-1s. A third for peptides. A lab system for diagnostics, spreadsheets for reconciliation, and a financing phone number that never answers. The practice is not slow. The vendor stack is slow.
FILE 01
The single-pharmacy hostage
Most ordering platforms are a front for one pharmacy. Every backorder, price increase, or capacity problem there becomes the practice's problem, and programs go dark through no fault of the practice.
FILE 02
The gray-market leak
Patients buy mystery vials from anonymous websites with no chain of custody. The practice loses revenue, the patient loses protection, and the category loses credibility.
FILE 03
The walk-out at the price tag
The patient wants the program, hesitates at the number, and leaves to think about it. Most never come back, and the practice absorbs the loss as a cost of doing business.
FILE 04
The operational tax
Even when everything works, the owner spends evenings as a supply-chain manager, a reimbursement chaser, and a spreadsheet accountant instead of a clinician and a business builder.
The answer, point by point
One platform replaces the patchwork. Storefront, formulary, ordering, clinical tools, fulfillment, financing, and analytics live under one login with one accountable partner.
Multi-pharmacy sourcing ends the hostage situation. Orders route across a U.S. 503A/503B network, so no single supplier's quarter can shut down a practice's programs.
Documented sourcing replaces the gray market. Chain of custody through licensed U.S. pharmacies gives the practice the compliant path patients are asking for.
Integrated patient financing ends the walk-out. Approval in minutes, the practice paid upfront and in full, and the patient on a plan they can accept on the same visit.
The operational tax comes down. Live dashboards, managed fulfillment, and one accountable relationship replace five unaccountable ones.
The practice owners this category is creating
04 · THE BACK OFFICE
The platform in full, module by module
This is the honest tour — the same one a practice receives in a professional appointment. Not a summary of features: the map of an operating environment, module by module and tool by tool, because a practice deciding where to run its longevity programs deserves to know exactly what it is standing on.
Every practice knows the moment: the patient who wants the program and hesitates at the number. MedFiAdvance is the category’s only patient-financing engine built directly into the ordering workflow — approval in minutes, no hold on the patient’s card, and the practice paid in full, same visit.
$399 →$4,500One patient, same visit — the hesitation became the full program, collected upfront.
The global GLP-1 weight-loss market stands near $60 billion and is projected to reach $150 to $190 billion by the early 2030s — compound annual growth in the range of 12 to 18 percent. The United States accounts for more than half of global demand, and J.P. Morgan forecasts the broader incretin market approaching $200 billion by 2030. Around that core, peptides, hormone optimization, IV therapy, and longevity protocols are compounding into one of the largest service categories in American medicine.
Providers standardizing on one platform, one login
$60BMarket today
400+Live offices
$60B
GLP-1 market today
$190B
Projected by the early 2030s
$200B
Incretin market by 2030 (J.P. Morgan)
The category curve12–18% CAGR
TODAY+1 YR+2 YR+3 YR+4 YREARLY 2030s
Demand is exploding while supply stays fragmented. The largest practitioner platforms do not carry compounded GLP-1s, peptides, and financing in one environment. Pharmacy-backed operations impose single-supplier lock-in. Lab portals route pharmacy outside the product. The second slot in the B2B longevity platform category is effectively vacant, and the infrastructure that wins this category will be chosen over the next 24 months.
PrescribeUSA enters that window with a head start no competitor can manufacture: seven years of technology, a platform live for more than two, and over four hundred doctor offices already operating on it. Onboarding is measured in days. The roadmap extends the same rails — telehealth integrations, additional 503A/503B/cGMP pharmacy sources, API integrations, category expansion, doctor upsell and patient-pay support, automated CRM sales expansion, and partner storefronts running on the platform's own architecture.
The timing question for a practice is simple. The category arrives whether or not any individual practice prepares for it. The practices that standardize on one platform now will hold the operating-cost and sourcing advantages for the life of their programs.
07 · THE THREE-PRONG APPROACH
Three channels. One flywheel.
PRONG ONE
The practices
Physicians, medspa owners, and clinic operators who need what the category demands — wholesale pricing, dependable multi-pharmacy sourcing, clinical tools, ship-to-patient fulfillment, and integrated financing — delivered as one partnership instead of a patchwork. The practice keeps its patients, its brand, and its clinical judgment. The platform carries the operational weight.
PRONG TWO
The Associates
Corporate pharmacy sales professionals who want out of B2C risk and exposure, entrepreneurs ready to build, and fitness coaches and people who’ve lived this path and want to represent best-in-class products and services — without the exposure of building a consumer brand: the ad spend, the platform bans, the liability, the compliance surface. A B2B relationship business with real infrastructure behind it.
PRONG THREE
The partners
Partner companies and vendors build their own storefronts and businesses on PrescribeUSA's commerce and distribution architecture. Every partner that goes live adds demand, volume, and strength to the same rails. Practices order, the network expands, partners come online — the flywheel compounds.
WHY THE MODEL WINS
Structural advantages
Multi-source supply that stays available when single-supplier platforms go dark. Clinical intelligence embedded where the ordering happens. Scalable distribution without re-platforming. Recurring revenue that compounds rather than resets. And financing as a moat — MedFiAdvance converts the patients other platforms lose.
08 · THE ULTIMATE SOLUTION
One operating environment for a longevity practice
Wholesale sourcing, built for practices like yours
503A/BPharmacy network
400+Offices proven
Taken together, the modules are the operating system for a longevity practice: the front door where the team orders, the sourcing that keeps the shelves full, the clinical suite that keeps the medicine precise, the fulfillment that reaches the patient, the financing that closes the treatment plan, and the dashboard that shows the owner the business. No practice should have to assemble this by hand, reconcile it by spreadsheet, and defend it in four support queues. PrescribeUSA exists so that no practice has to.
The competitive position is structural, not rhetorical. Supplement marketplaces do not carry the compounds. Single-pharmacy operations impose the lock-in. Lab portals route the pharmacy outside the product. No one else combines multi-pharmacy sourcing, the clinical suite, ship-to-patient fulfillment, and integrated patient financing in one environment — because building it required capital, patience, and operators who had done it before. It is built. It is live. It is proven across four hundred offices. And it is demonstrated, not described.
FOR ENTREPRENEURS & NURSE PRACTITIONERS — THE ASSOCIATE CHANNEL
09 · THE ASSOCIATE CHANNEL
Not an affiliate link. A professional channel.
PrescribeUSA opens the Associate channel to corporate pharmacy sales professionals who want out of B2C risk and exposure, entrepreneurs ready to build, and fitness coaches and people who’ve lived this path and want to represent best-in-class products and services — through a B2B channel, without building a consumer brand.
This is not an affiliate link, and it is not a pyramid of paperwork. It is a professional channel with real infrastructure: the Associate introduces practices to a platform they genuinely need, and the platform's partnership team carries onboarding, clinical support, fulfillment, and service. The Associate builds durable business relationships, and recurring revenue runs for the life of every account opened.
A multi-billion-dollar category that is still being organized — with a platform that already runs over four hundred doctor offices.
THE EXPOSURE
None of the consumer risk
No inventory, no fulfillment, no consumer-brand exposure, no ad-spend arms race. The platform carries the operational and compliance weight.
14 · THE PROFESSIONAL APPOINTMENT
Book an appointment. Watch the trust question end.
This category has earned its skepticism: portals with dashboards and no operations, marketers with funnels and no pharmacies, and vendors describing features they cannot show. Our answer is not a longer page. It is a professional appointment with the platform's senior team, run on the real platform, on screen. It is the fastest trust-elimination device in the industry for one reason: nothing is described that is not shown.
Associates get the same standard: a private intake with the senior partnership team — the economics, dashboards, and training system, demonstrated live, not described.
Senior operators, not script readers
LIVEOn the real platform
ZEROPressure
PRACTICE SIGN-UP
Book an appointment
A working session for physicians, medspa owners, and clinic operators — the full back office, on screen, with a senior operator.
Booked today, seated this week — senior operators, not script readers
The real platform, not slideware: storefront, sourcing, clinical suite, financing
Pricing, sourcing, compliance, and workflow questions answered on the spot
Zero pressure, full evidence — the platform does the persuading, or it does not
PrescribeUSA is one platform, front door to back office — seven years of technology, more than two years of live operation, and over four hundred doctor offices, growing daily — standing ready for every approved practice in America. Wholesale pricing, multi-pharmacy sourcing, the full clinical suite, ship-to-patient fulfillment, integrated financing, and a professional appointment whenever you are ready.
THE STANDARD
Wholesale only, to approved practices. Never direct to the consumer. There was never a ribbon to cut. The platform has been here the whole time — running quietly, correctly, at scale.
Today is simply the day you found us, and the day your search ended.
MEDFIADVANCE · PATIENT FINANCING, BUILT INTO THE PLATFORM
The hesitation has a number. So does the close.
The category’s only patient-financing engine built directly into the platform workflow — approval in minutes, no hold on the patient’s card, and the practice paid in full, same visit.
Approval at the point of decision — inside the ordering workflow
MODULE 07 · THE MEDFIADVANCE STRONG HOLD
The category's only integrated patient-financing engine
Longevity treatment plans are high-ticket, and every practice knows the moment: the patient who wants the program and hesitates at the number. PrescribeUSA carries the category's only patient-financing engine built directly into the platform workflow — MedFiAdvance — rather than bolted on as a phone number and a hope.
Approval in minutes
At the point of decision — no next-day callbacks, no lost momentum, no treatment plan that dies in a follow-up call.
Unlimited, no-hold credit
The patient's card is never tied up with a hold, the approval is not a reservation, and purchasing power stays with the patient.
Practice paid upfront, in full
No payment plans to administer, no balances to chase, no discounting to close. Financing converts the hesitation into a treatment plan on the same visit.
Unlimited use, per practice
No cap on how often financing is offered — every high-ticket plan in every category can carry it.
$399
WITHOUT FINANCING
The monthly quote the patient hesitates on — and the plan dies in a follow-up call. Collected by the practice: $0.
→
$4,500
WITH MEDFIADVANCE
Approved in minutes, the patient takes the full program upfront. The practice is paid in full — same visit.
The math on one patient: a $399 hesitation became a $4,500 program. Now run that across every high-ticket plan in the practice — that is financing inside the ordering workflow, not bolted on as a phone number and a hope.
Why it is a strong hold: no other B2B platform in the category integrates patient financing into the ordering workflow itself. For practices, it is the difference between a quote and a close — financed patients say yes more often, accounts order more consistently, and recurring revenue rides on a base that is structurally harder to lose.
Every high-ticket plan in the practice can carry it
Unlimited use per practice, no caps, no balances to chase. See MedFiAdvance demonstrated live, on the real platform, in a professional appointment.
THE ASSOCIATE PROGRAM · LIMITED GROUND-FLOOR POSITIONS
The PrimeBodyRX Opportunity.
Longevity, GLP-1s & Peptides is the fastest-growing category in modern medicine. We're opening a limited number of Associate spots to get in on the ground floor — before this market matures and the opportunity closes.
Ground-floor access to a multi-billion dollar, explosive growth category.
No inventory. No experience required. We built the infrastructure — you bring the hustle.
Backed by licensed medical infrastructure — not hype, not guesswork.
Build your own team, on your own hours, with real income potential.
Full training and support system — done-for-you scripts, no guesswork.
The people winning this category are already awake for it — the entrepreneurs and fitness enthusiasts whose morning starts with training, clean coffee, and an open laptop. The Associate channel was built for exactly that life: it turns the discipline you already live into recurring revenue, without asking you to build a consumer brand, buy inventory, or fund ads the platforms keep banning.
Explosive Emerging Market
$250K++Earning potential
$0Cost to begin
One laptop. One login. The whole platform
DAY 1Compounding starts
LIFEOf every account
Here is what an average morning actually looks like when you run this business:
Live it, then represent it. You already train, eat, and recover like the category's best customers — that authenticity is the pitch no ad can buy.
Mornings are yours. No inventory, no fulfillment, no storefront to babysit — the platform carries the operational weight while you open accounts.
One laptop, one login. Dashboards, live weekly training, and the full 140+ formulary in a single environment, open anywhere the sun finds you.
Compounding from day one. Recurring revenue from every account you open, running for the life of the account.
02 · WHAT AN ASSOCIATE GETS
The economics, in plain terms
Professional standards, real infrastructure
LIFEOf account revenue
$0Cost to start
Ground-floor access to a multi-billion-dollar category that is still being organized — with a platform that already runs over four hundred doctor offices.
No inventory, no fulfillment, no consumer-brand exposure, no ad-spend arms race. The platform carries the operational and compliance weight.
World-class training led by seven-figure earners, on live weekly calls built for working professionals.
Transparent dashboards tracking orders, referrals, downline relationships, and commission activity in real time.
Financing that compounds earnings. The MedFiAdvance engine converts patients other channels lose, so accounts order more and stay longer.
Recurring revenue for the life of every account opened.
Zero cost to begin, 21 and over, with professional references and standards required.
03 · WHY EARNINGS COMPOUND
MedFiAdvance strengthens every account you open
No other B2B platform in the category integrates patient financing into the ordering workflow itself. Approval in minutes, unlimited no-hold credit, and the practice paid upfront and in full. For an Associate, that means the accounts you open say yes more often, order more consistently, and generate recurring revenue that is structurally harder to lose.
PrimeBodyRX ambassadors operate like high-level pharmaceutical representatives: you introduce medical practices to the platform, build a book of business with lifetime account value, and carry a compliance standard no competitor can match.
You're not pitching a supplement. You're representing the compliance standard of the longevity industry — and opening doors a representative with an unverified product cannot.
Standard, not hype
THE WORK
Introduce medical practices.
Connect medspas, clinics and longevity practices to the platform they'll run their back office on.
Relationships — not transactions
THE ASSET
Build a book of business.
Develop long-term practice relationships with lifetime account value — not one-off transactions.
Compounds month after month
THE STANDARD
Carry verified claims only.
LegitScript-certified. HIPAA-secure. 503A/503B-sourced. Physician oversight on every order. You only represent what's verified.
✓ On file
05 · THE CORE OF THE PROGRAM
The four ways you earn.
Not one commission — four compounding income streams, all running on the same platform.
LONGEVITY BANKClarksburg, MD 20841
DATE09/10/2026PAY TO THE ORDER OFMARCUS T. REED$ 17,850.00
Refer a medspa, clinic, or provider — earn on every order they place, for the life of the account. One good referral becomes a recurring revenue stream that pays you month after month, year after year. You're not selling a product; you're building a book of business that compounds.
Every order — for the life of the account
INCOME STREAM 02
Ecosystem overrides.
When a practice or ambassador you brought in refers someone else into the PrimeBodyRX ecosystem, you earn on that too. Your network doesn't just grow — it pays you for growing.
Second-generation income
INCOME STREAM 03
Wholesale direct access.
Most of our ambassadors are entrepreneurs and longevity enthusiasts themselves. Verify you're 21+ with valid ID, agree to clinical-use-only terms, and buy direct from the warehouse at massive savings — the same 144+ product formulary the practices use. Never overpay retail again.
21+ verified — warehouse pricing
INCOME STREAM 04
Longevity finance residuals.
Our MedFiAdvance program — patient financing ($1K–$35K bundles) with instant payouts that let practices cancel subscription agreements — is one of the most powerful practice-winning tools we have. When your referred practices finance through MedFiAdvance, you earn a piece of the residual on those transactions. Huge, ongoing, and completely passive.
Passive, ongoing, compounding
06 · THE JOURNEY
Apply, learn and grow.
01
Apply.
Fill out the form, join the team and earn in the hottest market since the internet.
One form
02
Learn.
Daily demos, online training and access to information others have been searching for.
Daily demos · Live training
03
On Demand Support.
Digital assets, clinical talking points and live remote coaching from seven-figure leaders — on your phone the moment you need them.
Commissions, downline and payouts — every number of your Ambassador business in one dashboard, the same login your referred practices order through. Track orders, referrals, downline relationships and commission activity in real time, with live weekly training one click away.
The rare channel where credentials and ambition compound
Credentials and ambition, compounded
LTD.Positions open
REALStandards required
The consumer side of this category is a war zone: platforms ban the ads, click prices inflate, and single-supplier risk threatens every storefront. The B2B side carries none of that exposure. For entrepreneurs and fitness enthusiasts especially, this is the rare channel where the life you already live compounds — the discipline, the standards, and the credibility of someone who practices what they represent. You are the proof of the category, and that makes you its most convincing evangelist.
Positions are limited and standards are real, because the channel is only as strong as the people in it. Associates who qualify join the category while the ground floor still exists — and the window on that does not stay open long.
Positions are limited and standards are real. Tell the partnership team who you are, what you bring, and how to reach you. Every application is reviewed by the senior team — typically the same day — and qualified applicants move straight to a private intake with the partnership leads.
The lifestyle is the pitch — live it, then represent it.
SAME DAYReview turnaround
21+Age required
Application received.
The senior partnership team reviews every application — typically the same day. If you qualify, you will hear from us directly with your private intake.
PRIMEBODYMIND · THE LONGEVITY JOURNAL · WEALTH · HEALTH · MIND
A PRIMEBODYRX.COM PUBLICATION
The longevity economy, documented.
PrimeBodyMind is the journal of the fastest-growing category in medicine — the doctors leading it, the science underneath it, and the wealth being created by the people who showed up early with standards. Best practices from the field, documented since 2024.
VOL. 1 · EST. 2024 · UPDATED SEPTEMBER 2026|WRITTEN BY BROOKES BRUNO · FOUNDER, PRIMEBODYRX|PRIMEBODYRX.COM
01 · THE CATEGORY, IN NUMBERS
Read the numbers before you read anything else
The longevity economy, documented since 2024
$1T
Eli Lilly market value — the first drugmaker in history to cross a trillion, powered by GLP-1s
$200B
Projected GLP-1 market by 2030 — J.P. Morgan global research forecast
$78B
Projected medspa market by 2033, from $21B in 2024 — a 16% annual growth curve
$101M
XPRIZE Healthspan — the largest health prize in history, now in clinical trials with ten finalist teams
This is not a trend chart. It is a wealth-creation record — capital, clinics, and compounds moving in the same direction at the same time. The posts below document how it happened, and what the people winning are doing about it.
02 · THE JOURNAL — 2024 TO NOW
Best practices from the field, newest first
2026 · SEPTEMBER 6 MIN
MARKET
The category gets organized
The wild-west phase is ending. The consumer peptide channels are being banned and raided; the FTC and FDA are circling the gray market; and what replaces it is wholesale-only B2B infrastructure — 503A/503B sourcing networks, physician oversight, integrated financing, and one login for the entire practice economy. The best practice, written plainly: plug into infrastructure instead of building it. The winners of the next decade are the practices and professionals who chose systems over reinvention — and recurring revenue over one-off sales.
XPRIZE Healthspan — the largest health prize in history at $101 million — named its ten finalist teams, each awarded $1 million to test real therapies that restore muscle, cognitive, and immune function in people over 65. After two decades of theory, the science is now on a clock and moving toward the clinic. The best practice: position your practice now, because when functional healthspan therapies arrive, the patients and the capital will look for the practices that were already built for them.
Dr. Gabrielle Lyon’s muscle-centric medicine went mainstream with Forever Strong, and the clinical consensus moved with it: lean mass is the organ of longevity — the thing that protects against the falls, the frailty, and the glucose curves that end healthspans early. GLP-1-era medicine now pairs every weight-loss protocol with a strength protocol, and patients stay on plans they can feel. The best practice: protein-first, strength-first medicine — it is the protocol members actually keep paying for.
Living this — fitness, clean eating, real discipline — and want to represent it professionally instead of just posting about it? There’s a B2B channel built for people exactly like you. See the Associate Program →
2025 · FALL 4 MIN
WEALTH
The protocol economy gets funded
Bryan Johnson’s Blueprint raised $60 million to turn a personal longevity protocol into a product company — a watershed moment for the category. The message Wall Street sent: measured, documented protocols are sellable assets. Every practice running a documented protocol with outcomes data is holding the same asset at clinic scale. The best practice: write your protocols down, measure them, and treat them like products — because the market already does.
The longevity clinic stopped being a concept and became a membership business. The medspa market — $21 billion in 2024, projected toward $78 billion by 2033 — began consolidating around recurring protocol plans: GLP-1 management, peptide programs, hormone panels, IV therapy. The success stories repeating across the country are single-location practices that stopped selling one-off visits and started selling systems of care with monthly revenue. Same chairs, same square footage, entirely different business.
Dr. Peter Attia’s Outlive became the category’s defining book, and The Drive podcast became its faculty lounge. The result in clinics across the country: patients now arrive educated, asking for protocols by name — NAD+, peptides, GLP-1 maintenance, hormone optimization. The best practice: meet the informed patient with clinical documentation, not improvisation. The practices that could answer precisely are the ones that kept them.
Corporate pharmacy sales professionals and entrepreneurs are already building recurring revenue in this category through the Associate channel. See if you qualify →
2024 · FALL 5 MIN
MARKET
The front door moved
Telehealth made cash-pay medicine normal, and the medspa boom followed — U.S. medspas nearly doubled since 2018, on a trajectory toward 12,000+ locations. Patients stopped waiting on insurance and started expecting concierge speed from every practice they walk into. The best practice: be ready to consult, prescribe, ship, and finance in the same visit, because the patient who has to "think about it" is the patient who never comes back.
Eli Lilly became the first pharmaceutical company in history to cross $1 trillion in market value, powered by GLP-1 drugs. Wall Street’s answer was fast: J.P. Morgan projected the incretin market at $200 billion by 2030. The best practice the field took from 2024: when capital moves at that size, the services layer around it — prescribing, fulfillment, financing — is where practices capture durable value. The molecule makers got rich first. The practice economy is next.
From TED stages to the most-cited podcasts in medicine, these are the clinicians and scientists whose work built the category the market is now funding. Start anywhere — their lectures, books, and interviews are the curriculum.
Dr. Peter Attia
PHYSICIAN · AUTHOR, OUTLIVE
The category’s translator. His TED talks and The Drive podcast moved longevity from the lab to the living room — and "Medicine 3.0" into practice economics.
Dr. David Sinclair
HARVARD GENETICIST · AUTHOR, LIFESPAN
His TED talk on why we age remains one of the most-watched in the field. The sirtuin and information-theory work behind half the NAD+ industry.
Dr. Andrew Huberman
STANFORD NEUROSCIENTIST · HUBERMAN LAB
Brought the mind discipline to millions — sleep, light, dopamine, protocol-driven behavior. Proof the category is neurology as much as endocrinology.
Dr. Mark Hyman
FUNCTIONAL MEDICINE PIONEER
Made food-as-medicine a working clinic model and a bestseller shelf. The bridge from traditional practice to longevity practice design.
Dr. Valter Longo
USC · CREATOR, FASTING-MIMICKING DIET
Turned fasting science into a clinical protocol used in practices worldwide — the model for a measured, sellable, repeatable program.
Dr. Nir Barzilai
EINSTEIN COLLEGE OF MEDICINE · TAME TRIAL
Leading the scientific case that aging itself is a treatable condition — the trial the FDA world is watching.
Dr. Gabrielle Lyon
MUSCLE-CENTRIC MEDICINE · AUTHOR, FOREVER STRONG
Made lean mass the clinical priority of the category — and gave practices the protocol with the best adherence in the field.
Dr. Peter Diamandis
XPRIZE FOUNDER · FOUNTAIN LIFE
Made longevity investable at planetary scale — the $101M Healthspan prize and the longevity-clinic chain model.
Bryan Johnson
BLUEPRINT · THE CIVILIAN PROOF
Not a physician — the civilian who made protocols a headline, a movement, and then a $60M company. The demand curve, personified.
04 · THE WEALTH, BEING CREATED NOW
Positive stories, real money, honest math
THE MOLECULE MAKERS
The first trillion
Eli Lilly’s climb past $1 trillion in market value on GLP-1s, with Novo Nordisk beside it as Europe’s most valuable company — the fastest wealth creation in pharmaceutical history, built on the same molecules your practice prescribes.
THE PRACTICE OWNERS
$21B to $78B
The medspa and longevity-clinic economy is compounding at roughly 16% a year. The winners are ordinary practice owners who added recurring protocol revenue — GLP-1 management, peptide programs, hormones — to rooms they already owned.
THE CHANNEL BUILDERS
The associate economy
The newest layer: professionals who represent platforms to practices — corporate pharmacy sales pros, entrepreneurs, and fitness coaches earning recurring revenue for the life of every account they open. The same B2B wealth model that built every great distribution industry, arriving in longevity.
05 · THE PRIMEBODYMIND PLAYBOOK
Seven best practices, distilled from the record
01 — Sell the system, not the syringe. Protocols as memberships, not injections as transactions. Recurring revenue is the entire model.
02 — Meet the informed patient with documentation. They arrive holding a podcast. Answer it with clinical precision or lose them to someone who will.
03 — Close in the same visit. A high-ticket plan without financing at the point of decision is a plan that dies in the follow-up call.
04 — Buy wholesale, always. 503A/503B sourcing networks exist so practices stop paying retail and start compounding margin.
05 — One login beats nine subscriptions. Fragmented software is the silent tax on every practice that hasn’t consolidated.
06 — Choose the clinical channel, not the consumer channel. The gray market is being banned; the compliance-first practice economy is being built. One of them has a future.
07 — Position before the wave, not on it. XPRIZE therapies, GLP-1 expansion, and clinic consolidation are all moving in one direction. Early with standards beats late with budget.
06 · NOTES FROM THE FOUNDER’S DESK
Why this journal exists
I’ve spent my career building sales organizations and healthcare commerce infrastructure — turning fast-growing categories into systems that work on a Tuesday morning, not just in a pitch deck. I don’t claim to be the smartest person in longevity. I’ve simply been in enough emerging markets to know what an organized one looks like when it arrives, and this is that.
PrimeBodyMind is my running record of it: the doctors worth reading, the numbers worth trusting, the practices worth copying, and the wealth being created — honestly, transparently, and mostly by unglamorous people who showed up early and did the work. If it helps you see the category more clearly, it has done its job.
One life. This is it. Build accordingly.
Brookes BrunoFounder, PrimeBodyRX · primebodyrx.com · September 2026
07 · THE JOURNAL — NEWS · DIET · TRAINING · ALIGNMENT
The full-scope journal
Serious reading for people who take the long view — metabolic science, disciplined eating, training that ages well, and the alignment everything else sits on. No fluff, no fads, no filler.
